radioisotopic procedure or other procedure approved 
by the Food and Drug Administration performed on 
an individual for the purpose of identifying bone 
mass or detecting bone loss or determining bone 
quality, and includes a physician’s interpretation of 
the results of the procedure. Nothing in this para-
graph shall be construed as requiring a bone mass 
measurement to be conducted in a particular type of 
facility or to prevent such a measurement from 
being conducted through the use of mobile facilities 
that are otherwise qualified. 
‘‘(2) QUALIFIED INDIVIDUAL.—The term ‘quali-
fied individual’ means an individual who— 
‘‘(A) is at clinical risk for osteoporosis, in-
cluding an estrogen-deficient woman; 
‘‘(B) has vertebral abnormalities; 
‘‘(C) is receiving chemotherapy or long- 
term gluococorticoid (steroid) therapy; 
‘‘(D) has primary hyperparathyroidism, 
hyperthyroidism, or excess thyroid replacement; 
or 
‘‘(E) is being monitored to assess the re-
sponse to or efficacy of approved osteoporosis 
drug therapy. 
VerDate Aug 31 2005 
04:16 Jun 30, 2007
Jkt 059200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H2931.IH
H2931
cnoel on PRODPC60 with BILLS
‘‘(c) LIMITATION ON FREQUENCY REQUIRED.—The 
standards established under section 2707(c) of the Public 
Health Service Act shall apply to benefits provided under 
this section in the same manner as they apply to benefits 
provided under section 2707 of such Act. 
‘‘(d) RESTRICTIONS ON COST-SHARING.— 
‘‘(1) IN GENERAL.—Subject to paragraph (2), 
nothing in this section shall be construed as pre-
venting a group health plan or issuer from imposing 
deductibles, coinsurance, or other cost-sharing in re-
lation to bone mass measurement under the plan (or 
health insurance coverage offered in connection with 
a plan). 
‘‘(2) LIMITATION.—Deductibles, coinsurance, 
and other cost-sharing or other limitations for bone 
mass measurement may not be imposed under para-
graph (1) to the extent they exceed the deductibles, 
coinsurance, and limitations that are applied to simi-
lar services under the group health plan or health 
insurance coverage. 
‘‘(e) PROHIBITIONS.—A group health plan, and a 
health insurance issuer offering group health insurance 
coverage in connection with a group health plan, may 
not— 
VerDate Aug 31 2005 
04:16 Jun 30, 2007
Jkt 059200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H2931.IH
H2931
cnoel on PRODPC60 with BILLS
‘‘(1) deny to an individual eligibility, or contin-
ued eligibility, to enroll or to renew coverage under 
the terms of the plan, solely for the purpose of 
avoiding the requirements of this section; 
‘‘(2) provide incentives (monetary or otherwise) 
to individuals to encourage such individuals not to 
be provided bone mass measurements to which they 
are entitled under this section or to providers to in-
duce such providers not to provide such measure-
ments to qualified individuals; 
‘‘(3) prohibit a provider from discussing with a 
patient osteoporosis preventive techniques or medical 
treatment options relating to this section; or 
‘‘(4) penalize or otherwise reduce or limit the 
reimbursement of a provider because such provider 
provided bone mass measurements to a qualified in-
dividual in accordance with this section. 
‘‘(f) RULE OF CONSTRUCTION.—Nothing in this sec-
tion shall be construed to require an individual who is a 
participant or beneficiary to undergo bone mass measure-
ment. 
‘‘(g) NOTICE UNDER GROUP HEALTH PLAN.—The 
imposition of the requirements of this section shall be 
treated as a material modification in the terms of the plan 
described in section 102(a), for purposes of assuring no-
VerDate Aug 31 2005 
04:16 Jun 30, 2007
Jkt 059200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H2931.IH
H2931
cnoel on PRODPC60 with BILLS